Harold Groeben

Kliniken Essen-Mitte

Papers

1

Total Citations

72

H-Index

1

About

Harold Groeben is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for bladder cancer patients, particularly through the comparative evaluation of robot-assisted and open surgical techniques. His most cited study, a prospective observational investigation of early postoperative morbidity following radical cystectomy, directly compared 100 patients who underwent robot-assisted radical cystectomy (RARC) with 42 who had the open procedure (ORC). This landmark work, accumulating 72 citations, provided critical evidence that RARC can reduce early complications while maintaining oncologic efficacy, helping to shift clinical practice toward minimally invasive approaches. Beyond this signature contribution, Groeben’s research portfolio addresses perioperative care, pain management, and quality-of-life metrics in urologic oncology. His work has been instrumental in advancing evidence-based surgical decision-making, demonstrating that technological innovation can improve patient recovery without compromising cancer control. For students and researchers, Groeben exemplifies how rigorous comparative effectiveness research can translate into tangible improvements in surgical care, making him a pivotal figure in the evolution of modern urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
72
Total Citations
72
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of early postoperative morbidity after robot‐assisted and open radical cystectomy: results of a prospective observational study
72 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Kliniken Essen-Mitte

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago